Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nihon Medi-Physics Co. Ltd.

Latest From Nihon Medi-Physics Co. Ltd.

Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun

With Phase III data in 2,800 patients for reducing frown lines, ReVance anticipates filing RT002 for US approval in 2019. ABL licenses two bispecific antibody candidates to TRIGR, while Sun looks to expand in dermatology with Pola buyout.

Deals Asia Pacific

Endocyte Anticipating Positive CHMP Opinion On Ovarian Cancer Drug/Diagnostic Combo

Endocyte and Merck are preparing to launch a combo drug/diagnostic in folate receptor-positive platinum-resistant ovarian cancer, a condition with a very poor survival prognosis, later this year in the EU. Medical affairs staff are meeting with specialists to discuss how the diagnostic can target patients most likely to respond in pre-approval commercial efforts.

BioPharmaceutical United States

Roche’s Kadcyla Delayed In Japan And Simeprevir Gets First Market Nod In New Chuikyo Price Listings

Japan subsidiary Chugai will launch clinical trials in January to provide patients access to Kadcyla while the company renegotiates the reimbursement price for the antibody drug conjugate.

BioPharmaceutical Japan

Deals Shaping The Medical Industry, October 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August through September 2013.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Nihon Medi-Physics Co. Ltd.
  • Senior Management
  • Yutaka Takeuchi, Pres.
  • Contact Info
  • Nihon Medi-Physics Co. Ltd.
    Phone: (81) 03-5634-7006
    3-4-10, Shinsuna, Koto-ku
    Tokyo, 136-0075